Rho-kinase signalling mediates endotoxin hypersensitivity after partial hepatectomy

Area of Science:

• Hepatology
• Immunology
• Pharmacology

Background:

• Liver dysfunction after significant liver mass loss increases infection susceptibility.
• Rho-kinase's role in hepatectomy-induced endotoxin sensitization was investigated.

Purpose of the Study:

• To determine if Rho-kinase inhibition mitigates liver injury and inflammation following hepatectomy and endotoxin challenge.
• To elucidate the Rho-kinase-dependent mechanisms underlying increased susceptibility to endotoxin post-hepatectomy.

Main Methods:

• Male C57BL/6J mice underwent 68% hepatectomy, followed by Escherichia coli lipopolysaccharide (LPS) injection.
• Rho-kinase inhibitors (fasudil or Y-27632) or saline were administered concurrently with LPS.
• Liver injury markers (ALT, histology) and inflammatory parameters were assessed 6 hours post-LPS.

Main Results:

• Hepatectomy significantly increased susceptibility to LPS, evidenced by elevated leucocyte infiltration, hepatocellular damage (ALT), and apoptosis.
• Rho-kinase inhibition reduced leucocytic infiltration by over 33% and completely abolished hepatocellular apoptosis.
• Tumor necrosis factor-alpha and CXC chemokine expression decreased by over 48% and 36%, respectively, with Rho-kinase inhibition.

Conclusions:

• Hepatectomy enhances susceptibility to LPS through Rho-kinase-dependent pathways.
• Blocking Rho-kinase signaling effectively reduces LPS-induced liver injury in hepatectomized mice.
• Rho-kinase inhibition presents a promising therapeutic strategy for managing post-hepatectomy complications.